These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38636710)

  • 21. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.
    Riaz N; Hong JC; Sherman EJ; Morris L; Fury M; Ganly I; Wang TJ; Shi W; Wolden SL; Jackson A; Wong RJ; Zhang Z; Rao SD; Lee NY
    Radiother Oncol; 2014 Jun; 111(3):382-7. PubMed ID: 24993329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.
    Kim JK; Hardy-Abeloos C; Purswani JM; Kamen E; Concert CM; Duckworth T; Tam M; Haas J; Rybstein M; Vaezi A; Jacobson A; Hu KS
    Brachytherapy; 2023; 22(4):503-511. PubMed ID: 36593130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma.
    Lee A; Woods R; Mahfouz A; Kitpanit S; Cartano O; Mohamed N; Youssef I; Marqueen K; Sine K; Mah D; Neal B; Zakeri K; Kang JJ; Riaz N; Yu Y; McBride SM; Chen LD; Tsai CJ; Gelblum DY; Press RH; Michel LS; Sherman EJ; Pfister D; Dunn LA; Ho AL; Fetten J; Wong RJ; Boyle JO; Singh B; Cracchiolo JR; Ganly I; Cohen MA; Lee NY
    JAMA Netw Open; 2023 Jan; 6(1):e2250607. PubMed ID: 36689229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-irradiation for head and neck squamous cell carcinoma.
    Benson R; Giridhar P; Venkatesulu BP; Mallick S; Raza MW; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):1-9. PubMed ID: 27595192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
    Tao Y; Faivre L; Laprie A; Boisselier P; Ferron C; Jung GM; Racadot S; Gery B; Even C; Breuskin I; Bourhis J; Janot F
    Radiother Oncol; 2018 Sep; 128(3):467-471. PubMed ID: 29784451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and selection criteria in the retreatment of head and neck cancers.
    May ME; Cash ED; Silverman CL; Redman RA; Perez CA; Wilson LD; Tennant PA; Bumpous JM; Dunlap NE
    Oral Oncol; 2019 Jan; 88():85-90. PubMed ID: 30616802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recurrent head and neck carcinoma.
    Strnad V; Lotter M; Kreppner S; Fietkau R
    Brachytherapy; 2014; 13(2):187-95. PubMed ID: 24211123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reirradiation of head and neck cancer: Long-term disease control and toxicity.
    Bots WTC; van den Bosch S; Zwijnenburg EM; Dijkema T; van den Broek GB; Weijs WLJ; Verhoef LCG; Kaanders JHAM
    Head Neck; 2017 Jun; 39(6):1122-1130. PubMed ID: 28263446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
    Ohnleiter T; Antoni D; Lefebvre F; Truntzer P; Schultz P; Burgy M; Borel C; Noël G
    Chin Clin Oncol; 2018 Dec; 7(6):60. PubMed ID: 30180748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
    von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
    Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer.
    Hayashi Y; Nakamura T; Mitsudo K; Kimura K; Yamaguchi H; Ono T; Azami Y; Takayama K; Hirose K; Yabuuchi T; Suzuki M; Hatayama Y; Kikuchi Y; Wada H; Fuwa N; Hareyama M; Tohnai I
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e394-e401. PubMed ID: 27220486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Orlandi E; Bonomo P; Ferella L; D'Angelo E; Maddalo M; Alterio D; Infante G; Bacigalupo A; Argenone A; Iacovelli NA; Desideri I; Meduri B; Triggiani L; Volpe S; Belgioia L; Dionisi F; Romanello DA; Fallai C; Miceli R
    Head Neck; 2019 Oct; 41(10):3684-3692. PubMed ID: 31355972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-irradiation for isolated neck recurrence in head and neck tumor: impact of rN category.
    Yamazaki H; Suzuki G; Aibe N; Shiomi H; Oh RJ; Yoshida K; Nakamura S; Konishi K; Matsuyama T; Ogita M
    Sci Rep; 2024 Feb; 14(1):3107. PubMed ID: 38326404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection.
    Embring A; Onjukka E; Mercke C; Lax I; Berglund A; Bornedal S; Wennberg B; Friesland S
    Radiat Oncol; 2020 Jun; 15(1):147. PubMed ID: 32513217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
    McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensity-modulated radiotherapy for recurrent and second primary head and neck cancer in previously irradiated territory.
    Duprez F; Madani I; Bonte K; Boterberg T; Vakaet L; Derie C; De Gersem W; De Neve W
    Radiother Oncol; 2009 Dec; 93(3):563-9. PubMed ID: 19919885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.